HomeCompareTAISF vs VICI

TAISF vs VICI: Dividend Comparison 2026

TAISF yields 1.25% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $945.4K in total portfolio value
10 years
TAISF
TAISF
● Live price
1.25%
Share price
$59.00
Annual div
$0.74
5Y div CAGR
-8.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$52.75
Full TAISF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — TAISF vs VICI

📍 VICI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTAISFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TAISF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TAISF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TAISF
Annual income on $10K today (after 15% tax)
$106.61/yr
After 10yr DRIP, annual income (after tax)
$44.84/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $516,224.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TAISF + VICI for your $10,000?

TAISF: 50%VICI: 50%
100% VICI50/50100% TAISF
Portfolio after 10yr
$493.5K
Annual income
$303,714.43/yr
Blended yield
61.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

TAISF
No analyst data
Altman Z
1.8
Piotroski
6/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TAISF buys
0
VICI buys
11
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002024-10-14
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002024-03-25
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002024-02-13
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002023-11-03
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-10-10
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002023-09-06
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-08-29
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-07-28
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-06-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTAISFVICI
Forward yield1.25%6.52%
Annual dividend / share$0.74$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-8.8%44.3%
Portfolio after 10y$20.8K$966.2K
Annual income after 10y$52.75$607,376.13
Total dividends collected$805.00$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TAISF vs VICI ($10,000, DRIP)

YearTAISF PortfolioTAISF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$10,814$114.39$11,361$941.49$547.00VICI
2$11,677$105.44$13,320$1,481.32$1.6KVICI
3$12,591$97.03$16,284$2,405.01$3.7KVICI
4$13,562$89.18$21,040$4,071.78$7.5KVICI
5$14,593$81.87$29,209$7,285.49$14.6KVICI
6$15,690$75.09$44,443$14,006.51$28.8KVICI
7$16,857$68.81$75,822$29,512.55$59.0KVICI
8$18,100$63.01$148,733$69,726.75$130.6KVICI
9$19,424$57.67$344,394$189,413.75$325.0KVICI
10$20,837$52.75$966,234$607,376.13$945.4KVICI

TAISF vs VICI: Complete Analysis 2026

TAISFStock

Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The Self-Medication Operation Group segment offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the Colac series of laxative products; the Naron series and other products for antipyretic analgesics; the Preser series of hemorrhoid treatment products; Hapacol, Efferalgan, Dafalgan, and Tempra for antipyretic analgesics; Counterpain topical anti-inflammatory analgesics; Vitacilina, a dermatological treatment product; and VICKS, a cough suppressant throat lozenges and medicated drops. This segment also engages in the real estate leasing and facility management, and hotel management operations. The Prescription Pharmaceutical Operation Group segment offers ethical drugs, including Edirol, an active vitamin D3 osteoporosis agent; Clarith, a macrolide antibiotic; Palux, a peripheral vasodilator; Bonviva, a bisphosphonate osteoporosis agent; Lusefi, a type 2 diabetes mellitus agent; and LOQOA, a transdermal anti-inflammatory analgesic. This segment has various products under development primarily in therapeutic areas, such as central nervous system, infectious, and metabolic diseases, as well as orthopedic disorders. The company also offers raw materials for pharmaceuticals and quasi-drugs; and supplies health foods and skin care products. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan.

Full TAISF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this TAISF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TAISF vs SCHDTAISF vs JEPITAISF vs OTAISF vs KOTAISF vs MAINTAISF vs NNNTAISF vs EPRTTAISF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.